FT Options’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$32K Sell
31,500
-33,300
-51% -$2.4M 0.05% 145
2017
Q2
$126K Buy
64,800
+5,800
+10% +$431K 0.22% 71
2017
Q1
$206K Buy
59,000
+3,500
+6% +$245K 0.27% 78
2016
Q4
$12K Sell
55,500
-173,600
-76% -$11.9M 0.01% 198
2016
Q3
$168K Sell
229,100
-74,900
-25% -$5.54M 0.13% 116
2016
Q2
$271K Buy
304,000
+177,200
+140% +$12.6M 0.23% 80
2016
Q1
$146K Buy
+126,800
New +$8.44M 0.15% 106

Other funds holding CL

FT Options's CL Position: Q3 2017 in Review

FT Options reduced its Colgate-Palmolive (CL) stake by 93% in Q3 2017, selling an estimated $926K and leaving 900 shares worth $66K. The position accounts for 0.1% of the portfolio, ranked #115.

FT Options first reported a position in CL in Q4 2016 and has held it in 3 quarters since. The position peaked at $1.02M in Q2 2017. 1,357 funds tracked by Wall St. Rank hold CL as of Q3 2017.

  • FT Options held 900 shares of Colgate-Palmolive worth $66K as of Q3 2017.
  • FT Options sold 12,847 Colgate-Palmolive shares in Q3 2017, an estimated $926K.
  • Colgate-Palmolive made up 0.1% of FT Options's portfolio in Q3 2017, its #115 holding.
  • FT Options first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 3 quarters since.
  • FT Options's Colgate-Palmolive position peaked at $1.02M in Q2 2017.
  • 1,357 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.